American Vietnamese Biotech, Inc.

  • Market Cap: N/A
  • Industry: Medical Specialties
  • ISIN: VN000000AMV5
VND
2,000.00
-200 (-9.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
63,555.05
2,22,710.26
5,708.69
35,467.62
45,940.57
45,361.91
52,934.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
63,555.05
2,22,710.26
5,708.69
35,467.62
45,940.57
45,361.91
52,934.51
Raw Material Cost
56,610.50
1,93,789.60
8,379.17
36,305.54
38,644.35
34,015.49
37,831.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5,444.86
5,015.51
4,444.41
11,082.26
3,303.78
4,936.17
5,361.94
Selling and Distribution Expenses
4,609.48
-34,028.10
-52,520.47
99,053.48
2,742.37
4,620.43
3,568.53
Other Expenses
-544.49
-501.55
-444.44
-1,108.23
-330.38
-493.62
-536.19
Total Expenditure (Excl Depreciation)
61,219.98
1,59,761.50
-44,141.31
1,35,359.01
41,386.73
38,635.92
41,400.44
Operating Profit (PBDIT) excl Other Income
2335.1
62948.8
49850
-99891.4
4553.8
6726
11534.1
Other Income
390.34
13,868.41
138.58
24.98
203.56
2,969.51
-1,250.76
Operating Profit (PBDIT)
11,307.97
84,103.50
56,415.45
-94,917.64
10,040.27
15,181.66
15,763.72
Interest
5,444.86
5,015.51
4,444.41
11,082.26
3,303.78
4,936.17
5,361.94
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
6,944.55
28,920.66
-2,670.48
-837.91
7,296.21
11,346.42
15,102.61
Depreciation
8,582.56
7,286.33
6,426.87
4,948.77
5,282.87
5,486.17
5,480.41
Profit Before Tax
-2,719.45
71,801.66
45,544.17
-1,10,948.67
1,453.63
4,759.32
4,921.38
Tax
-784.86
2,949.58
0.00
0.00
0.00
697.31
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-3,070.83
67,052.13
44,259.76
-1,08,233.48
1,551.80
4,059.27
4,870.74
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-3,070.83
67,052.13
44,259.76
-1,08,233.48
1,551.80
4,059.27
4,870.74
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-316.16
233.31
1,062.93
-2,715.19
-98.17
2.73
50.64
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-3,386.99
67,285.45
45,322.69
-1,10,948.67
1,453.63
4,062.00
4,921.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
16,19,551.37
16,02,490.37
15,55,348.58
15,11,088.82
16,19,420.48
16,17,868.68
16,14,165.39
Earnings per share (EPS)
-23.42
511.44
337.59
-825.54
11.84
30.96
37.15
Diluted Earnings per share
-23.42
511.44
337.59
-825.54
11.84
30.96
37.15
Operating Profit Margin (Excl OI)
3.67%
28.26%
873.23%
-281.64%
9.91%
14.83%
21.79%
Gross Profit Margin
9.23%
35.51%
910.38%
-298.86%
14.66%
22.59%
19.65%
PAT Margin
-4.83%
30.11%
775.3%
-305.16%
3.38%
8.95%
9.2%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2025 is -71.46% vs 3,801.24% in Dec 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2025 is -105.03% vs 48.46% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2025 is -84.46% vs 24.80% in Dec 2024

stock-summary

Interest

QoQ Growth in quarter ended Mar 2025 is 8.56% vs 12.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

Compare Quarterly Results Of American Vietnamese Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
63,555.05
0
63,555.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
63,555.05
0
63,555.05
Raw Material Cost
56,610.50
0
56,610.50
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5,444.86
0
5,444.86
Selling and Distribution Expenses
4,609.48
0
4,609.48
Other Expenses
-544.49
0.00
-544.49
Total Expenditure (Excl Depreciation)
61,219.98
0
61,219.98
Operating Profit (PBDIT) excl Other Income
2,335.07
0.00
2,335.07
Other Income
390.34
0
390.34
Operating Profit (PBDIT)
11,307.97
0
11,307.97
Interest
5,444.86
0
5,444.86
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
6,944.55
0
6,944.55
Depreciation
8,582.56
0
8,582.56
Profit Before Tax
-2,719.45
0
-2,719.45
Tax
-784.86
0
-784.86
Provisions and contingencies
0
0
0.00
Profit After Tax
-3,070.83
0
-3,070.83
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-3,070.83
0
-3,070.83
Share in Profit of Associates
0
0
0.00
Minority Interest
-316.16
0
-316.16
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-3,386.99
0
-3,386.99
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
16,19,551.37
0
16,19,551.37
Earnings per share (EPS)
-23.42
0
-23.42
Diluted Earnings per share
-23.42
0
-23.42
Operating Profit Margin (Excl OI)
3.67%
0%
0.00
3.67%
Gross Profit Margin
9.23%
0%
0.00
9.23%
PAT Margin
-4.83%
0%
0.00
-4.83%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 6,355.50 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -71.46% vs 3,801.24% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 38.34% vs 7.00% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -338.70 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -105.03% vs 48.46% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -333.01% vs -41.62% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,091.76 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -84.46% vs 24.80% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 10.99% vs -23.32% in Mar 2024

Quarterly - Interest
Interest 544.49 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 8.56% vs 12.85% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 64.81% vs -34.61% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.67%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024